Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
09/24/2003 | CN1444653A Therapeutic compounds |
09/24/2003 | CN1444652A Mammalian receptor proteins, related regents and methods |
09/24/2003 | CN1444651A Generation of libraries of antibodies in yeast and uses thereof |
09/24/2003 | CN1444602A Human receptor proteins, related reagents and methods |
09/24/2003 | CN1444598A Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of immune response to amyloid beta and amyloid deposits |
09/24/2003 | CN1443850A Method for preparing recombinant human CTLA4 extracellular region protein, and obtained product and application |
09/24/2003 | CN1443778A Monoclonal antibody of melanic related antigen, and its application and medicine composition |
09/24/2003 | CN1443777A Monoclonal antibody capable of identifying tumor cell surface antigen and its preparation and application |
09/24/2003 | CN1443775A Leptospira outer membrane protein and its code sequence |
09/24/2003 | CN1443773A Leptospira pathogenic related protein and its code squence |
09/24/2003 | CN1122107C Intracellular antifreeze polypeptide and nucleic acids |
09/23/2003 | US6624295 Heavy chain and light chain peptides comprising complement determining regions, including single chain FV fragments, used as thrombolytic agents |
09/23/2003 | US6623981 Detecting antibodies which bind integrin bound modulators; obtain sample, incubate with modulators and antibodies, form complexes, screen for bound complex |
09/23/2003 | US6623980 Mixing polypeptides with exogeneous proteins, oligopeptides, polysaccharides or polynucleotides, then analyzing binding; medical diagnosis and therapy |
09/23/2003 | US6623960 Monoclonal antibodies comprising complementarity determining regions (CDRs) from light chain and heavy chain variable domain peptides used for drug screening; metabolism of xenobiotics and carcinogens |
09/23/2003 | US6623957 Immunotherapy for T-cell mediated autoimmune disease |
09/23/2003 | US6623942 Nucleotide sequences coding polypetide for use in treatment of hematopoietic and immunological disorders; wound healing agents |
09/23/2003 | US6623940 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
09/23/2003 | US6623938 Human I-FLICE (Inhibitor of FLICE (FADD-like ICE)) polynucleotides; vectors, host cells and recombinant methods for producing the same |
09/23/2003 | US6623936 Compositions and methods for improved detection and classification of neoplasms |
09/23/2003 | US6623934 For isolation of proteins that may be used to induce bone and/or cartilage or other connective tissue formation, and in wound healing and tissue repair |
09/23/2003 | US6623738 Polypeptide consisting of amino acid sequence 2 or 4 which is not cross reactive with mouse, chick nor drosophila neuro-pilin-1 |
09/23/2003 | US6623737 Epitopes; medical diagnosis |
09/23/2003 | US6623736 Interleukin antagonists for the treatment of neurological, retinal and muscular disorders |
09/23/2003 | US6623735 Vaccine containing a thiol protease |
09/23/2003 | CA2164818C Tandem synthetic hiv-1 peptides |
09/23/2003 | CA2139632C Assay for chagas' disease and reagents for its use |
09/23/2003 | CA2139518C Antigenic regions of tlp complexes and antibodies against the same |
09/23/2003 | CA2113099C Differentiation of htlv-i and htlv-ii using synthetic peptides |
09/23/2003 | CA2112907C Peptide which abrogates tnf and/or lps toxicity |
09/23/2003 | CA2082424C Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
09/18/2003 | WO2003076947A2 Method for monitoring collagen type ii degradation in cartilage |
09/18/2003 | WO2003076946A2 Detection of specific nitrated protein markers |
09/18/2003 | WO2003076934A1 Sandwich assay kits for detecting shigatoxin ctx3c |
09/18/2003 | WO2003076898A2 Mycobacterial diagnostics |
09/18/2003 | WO2003076662A1 Identification of microbial polynucleotides expressed during infection of a host |
09/18/2003 | WO2003076631A2 Genetic products differentially expressed in tumors and use thereof |
09/18/2003 | WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene |
09/18/2003 | WO2003076610A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
09/18/2003 | WO2003076579A2 Cancer-linked gene as target for chemotherapy |
09/18/2003 | WO2003076571A2 Cancer-linked gene as target for chemotherapy |
09/18/2003 | WO2003076570A2 Antigens and their use as diagnostics and vaccines against species of plasmodium |
09/18/2003 | WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
09/18/2003 | WO2003076568A2 Immunotherapeutics for biodefense |
09/18/2003 | WO2003076473A1 Specific ab1'-antibodies against tumour-associated antigen ca 125 |
09/18/2003 | WO2003076472A2 Neoplasm specific antibodies and uses thereof |
09/18/2003 | WO2003076471A2 A multifunctional complex for targeting specific phagocytosis of a target agent |
09/18/2003 | WO2003076470A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins |
09/18/2003 | WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature |
09/18/2003 | WO2003076465A2 Downregulation of ca 125 tumor antigen and uses thereof |
09/18/2003 | WO2003076455A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
09/18/2003 | WO2003075960A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
09/18/2003 | WO2003075957A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
09/18/2003 | WO2003075951A2 Novel application of vaccination against tnf-alpha |
09/18/2003 | WO2003075947A1 Use of egfr transactivation inhibitors in human cancer |
09/18/2003 | WO2003075925A1 Methods for reducing body fat and increasing a lean body mass by reducing stearoyl-coa desaturase 1 activity |
09/18/2003 | WO2003075860A2 Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof |
09/18/2003 | WO2003075855A2 Antibodies against cancer antigen tmeff2 and uses thereof |
09/18/2003 | WO2003075846A2 Uses of monoclonal antibody 8h9 |
09/18/2003 | WO2003075845A2 Immunogenicity of glucan binding protein |
09/18/2003 | WO2003075844A2 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
09/18/2003 | WO2003075841A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
09/18/2003 | WO2003075840A2 Human antibodies specific to kdr and uses thereof |
09/18/2003 | WO2003075831A2 NOVEL p53BP2 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME |
09/18/2003 | WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
09/18/2003 | WO2003059252A3 Use of a novel cell surface protease from group b streptococcus |
09/18/2003 | WO2003057163A3 Methods for preparing immunoconjugates |
09/18/2003 | WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
09/18/2003 | WO2003027226A3 A method for producing antibody in avian species by intra-muscular injection of coding sequence |
09/18/2003 | WO2003025124A3 Immunoglobulin having particular framework scaffold and methods of making and using |
09/18/2003 | WO2002100901A3 Determination of bone-sialoprotein in bodily fluids for oncological problems |
09/18/2003 | WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
09/18/2003 | WO2002094868A3 Staphylococcus aureus proteins and nucleic acids |
09/18/2003 | WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
09/18/2003 | WO2002077174A3 Human cytokine receptor |
09/18/2003 | WO2002072790A3 Tsg101-gag interaction and use thereof |
09/18/2003 | WO2002066646A3 Neurotransmission-associated proteins |
09/18/2003 | WO2002059308A3 Method of diagnosing and treating cartilage disorders |
09/18/2003 | WO2002053177A3 Agents and methods for treating pain |
09/18/2003 | WO2002036625A9 Prokineticin polypeptides, related compositions and methods |
09/18/2003 | WO2002031181A3 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
09/18/2003 | US20030177511 Antitumor, anticancer agents |
09/18/2003 | US20030176689 Inhibitors of hepatitis C virus protease |
09/18/2003 | US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
09/18/2003 | US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease |
09/18/2003 | US20030176684 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/18/2003 | US20030176679 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
09/18/2003 | US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna |
09/18/2003 | US20030176676 Methods of treating vascular inflammatory pathologies using chimeric anti-TNF antibodies |
09/18/2003 | US20030176674 Vascular endothelial growth factor 2 |
09/18/2003 | US20030176666 Hypothalamus-specific polypeptides |
09/18/2003 | US20030176664 Use of anti-tissue factor antibodies for treating thromboses |
09/18/2003 | US20030176663 Specific binding molecules for scintigraphy |
09/18/2003 | US20030176661 Novel antibody with specificity for colon cancer |
09/18/2003 | US20030176660 Avian transgenic antibodies; chromatography |
09/18/2003 | US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
09/18/2003 | US20030176648 Ion channel |
09/18/2003 | US20030176647 Antibodies to OCIF-binding molecules |
09/18/2003 | US20030176349 Stable hypoxia inducible factor-1 alpha and method of use |
09/18/2003 | US20030176348 For use as therapeutic agent for a syndrome resembling premature aging, a therapeutic agent for adult diseases or an aging-suppressing agent |